Company page

Longbio Pharma (suzhou) Co., Ltd. Class H

Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, has a market capitalization of approximately HKD 1.35 billion. The company is focused on the pharmaceutical sector, contributing to advancements in healthcare. As a public entity, it is subject to regulatory oversight and reporting requirements in Hong Kong.